Business Description
As of June 18, 2024, Atlantic International Corp. was acquired by Lyneer Investments, LLC, in a reverse merger transaction. Atlantic International Corp. operates as a life sciences instrumentation and research services company. It focuses on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provides solutions for various applications, such as biomarker discovery and diagnostic assay developments, including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and Weizmann Institute of Science for developed and applied innovative single-molecule technologies. The company was formerly known as SeqLL Inc. and changed its name to Atlantic International Corp. in June 2024. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
Business History
Price Overview
Last updated: May 11, 2026 1:56pm (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -1.08
Total Equity: -$32.09M
Shares: 54,846,155
Total Debt: $38.36M
Cash: $81,134
EBITDA: -$43.64M
Total Debt: $38.36M
Cash: $81,134
Revenue: $435.88M
Revenue: $435.88M
Revenue: $435.88M
Total Equity: -$32.09M
Tax Rate: -0.1%
Equity: -$32.09M
Total Debt: $38.36M
Cash: $81,134
Current Liabilities: $114.95M
Long-Term Debt: $30.37M
Total Debt: $38.36M
Total Equity: -$32.09M
Shares: 54,846,155
Shares: 54,846,155
CapEx: -$66,768
Shares: 54,846,155
Stock Price: $1.65
Net Income: -$59.43M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $425.0M | $441.5M | $401.4M | $442.6M | $435.9M |
| Cost of Revenue | $370.6M | $387.3M | $354.5M | $395.4M | $389.9M |
| Gross Profit | $54.4M | $54.2M | $46.9M | $47.2M | $46.0M |
| Operating Expenses | $90.1M | $48.2M | $50.3M | $69.0M | $96.2M |
| Operating Income | -$35.7M | $6.0M | -$3.5M | -$21.8M | -$50.2M |
| Net Income | -$40.8M | -$3.2M | -$15.3M | -$135.5M | -$59.4M |
| EBITDA | $12.2M | $11.9M | $1.4M | -$113.1M | -$43.6M |
| EPS | $-0.17 | $-0.19 | $-0.60 | $-3.68 | $-1.08 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4.0M | $2.2M | $1.4M | $678,676 | $81,134 |
| Total Current Assets | $10.4M | $6.6M | $78.8M | $88.0M | $81.2M |
| Total Assets | $10.7M | $8.4M | $126.7M | $122.8M | $113.2M |
| Current Liabilities | $2.6M | $1.2M | $161.6M | $97.2M | $115.0M |
| Long-Term Debt | $0 | $1.4M | $980,851 | $36.7M | $30.4M |
| Total Liabilities | $2.6M | $4.0M | $166.0M | $134.8M | $145.3M |
| Total Equity | $8.2M | $4.4M | -$39.4M | -$12.0M | -$32.1M |
| Retained Earnings | -$14.4M | -$18.5M | -$61.8M | -$135.5M | -$194.9M |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$2.0M | -$3.7M | -$9.1M | -$6.0M | -$4.4M |
| Capital Expenditure | $-14,470 | $-40,020 | $-73,711 | $-73,456 | $-66,768 |
| Free Cash Flow | -$2.0M | -$3.7M | -$9.2M | -$6.1M | -$4.5M |
| Acquisitions (net) | $0 | $0 | $0 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $4.0M | -$1.8M | $-363,234 | $-674,251 | $-597,542 |
Analyst Estimates (Annual)
| Metric | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Revenue |
$442.6M $442.6M – $442.6M
|
$440.2M $440.2M – $440.2M
|
$481.1M $481.1M – $481.1M
|
$37.5M $37.5M – $37.5M
|
| EBITDA |
-$105.9M -$105.9M – -$105.9M
|
-$26.1M -$26.1M – -$26.1M
|
-$28.5M -$28.5M – -$28.5M
|
-$2.2M -$2.2M – -$2.2M
|
| Net Income |
-$691.5M -$691.5M – -$691.5M
|
-$43.9M -$43.9M – -$43.9M
|
-$33.5M -$33.5M – -$33.5M
|
-$636.2M -$636.2M – -$636.2M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +3.9% | -9.1% | +10.3% | -1.5% |
| Gross Profit Growth | -0.4% | -13.5% | +0.6% | -2.5% |
| Operating Income Growth | +116.7% | -157.7% | -532.6% | -130.1% |
| Net Income Growth | +92.1% | -373.5% | -788.3% | +56.1% |
| EBITDA Growth | -2.0% | -88.0% | -7,973.0% | +61.4% |